Who is sponsoring NCT03438903?

NCT03438903 is sponsored by Hanyang University.

What drugs are being tested in NCT03438903?

Interventions in NCT03438903: Repeat exams of OCT device.

What condition does NCT03438903 study?

NCT03438903 studies Macula Abnormality.

Is NCT03438903 still recruiting?

NCT03438903 is currently completed. Last updated 20 February 2018.

Last reviewed 2018-02-20 · How we verify

NCT03438903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Repeatability Between SS and SD-OCT for Measuring Retinal Thickness in Various Retinal Diseases

Completed Last updated 20 February 2018

What this trial tests

trial testing Repeat exams of OCT device in Macula Abnormality in 114 participants. Completed in 31 January 2018.

Timeline

1 October 2017

Primary endpoint
31 January 2018

31 January 2018

Quick facts

Lead sponsor	Hanyang University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	114
Start date	1 October 2017
Primary completion	31 January 2018
Estimated completion	31 January 2018
Sites	1 location across South Korea

Drugs / interventions tested

Repeat exams of OCT device

Conditions studied

Macula Abnormality — all drugs for Macula Abnormality →

Sponsor

Hanyang University

Who can join

Adults 19 to 80, any sex, with Macula Abnormality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of intradevice repeatability of thickness measurements for macular area in the eyes with normal and various retinal diseases using SS-OCT and SD-OCT

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hanyang University trials

Trials by the same sponsor.

NCT06230302 — Efficacy and Safety of Kefir Whey Postbiotics · NA · unknown
NCT05579158 — Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Ran · NA · completed
NCT06812091 — Human Microbiome Research and Development for Overcoming Pediatric Diseases · recruiting
NCT04449224 — Comparative Effectiveness of Targeted Therapy in RA Patients · unknown
NCT03983408 — Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03438903 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hanyang University
Last refreshed: 20 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03438903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing